Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	17.45B
Revenue (ttm)	4.28B
Net Income (ttm)	1.12B
Shares Out	84.72M
EPS (ttm)	13.22
PE Ratio	15.58
Forward PE	14.21
Dividend	7.50 (3.66%)
Ex-Dividend Date	Mar 26, 2025

Volume	99,595
Average Volume	123,043
Open	204.50
Previous Close	205.00
Day's Range	202.00 - 206.00
52-Week Range	158.50 - 264.00
Beta	0.52
RSI	59.34
Earnings Date	Aug 11, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.